Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Synthesis Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CRO Peptides
1.2.3 CMO Peptides
1.2.4 Generic API Peptides
1.3 Market by Application
1.3.1 Global Peptide Synthesis Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Synthesis Service Market Perspective (2019-2030)
2.2 Peptide Synthesis Service Growth Trends by Region
2.2.1 Global Peptide Synthesis Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Synthesis Service Historic Market Size by Region (2019-2024)
2.2.3 Peptide Synthesis Service Forecasted Market Size by Region (2025-2030)
2.3 Peptide Synthesis Service Market Dynamics
2.3.1 Peptide Synthesis Service Industry Trends
2.3.2 Peptide Synthesis Service Market Drivers
2.3.3 Peptide Synthesis Service Market Challenges
2.3.4 Peptide Synthesis Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Synthesis Service Players by Revenue
3.1.1 Global Top Peptide Synthesis Service Players by Revenue (2019-2024)
3.1.2 Global Peptide Synthesis Service Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Synthesis Service Revenue
3.4 Global Peptide Synthesis Service Market Concentration Ratio
3.4.1 Global Peptide Synthesis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Synthesis Service Revenue in 2023
3.5 Peptide Synthesis Service Key Players Head office and Area Served
3.6 Key Players Peptide Synthesis Service Product Solution and Service
3.7 Date of Enter into Peptide Synthesis Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Synthesis Service Breakdown Data by Type
4.1 Global Peptide Synthesis Service Historic Market Size by Type (2019-2024)
4.2 Global Peptide Synthesis Service Forecasted Market Size by Type (2025-2030)
5 Peptide Synthesis Service Breakdown Data by Application
5.1 Global Peptide Synthesis Service Historic Market Size by Application (2019-2024)
5.2 Global Peptide Synthesis Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peptide Synthesis Service Market Size (2019-2030)
6.2 North America Peptide Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peptide Synthesis Service Market Size by Country (2019-2024)
6.4 North America Peptide Synthesis Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Synthesis Service Market Size (2019-2030)
7.2 Europe Peptide Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peptide Synthesis Service Market Size by Country (2019-2024)
7.4 Europe Peptide Synthesis Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Synthesis Service Market Size (2019-2030)
8.2 Asia-Pacific Peptide Synthesis Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peptide Synthesis Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Peptide Synthesis Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Synthesis Service Market Size (2019-2030)
9.2 Latin America Peptide Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peptide Synthesis Service Market Size by Country (2019-2024)
9.4 Latin America Peptide Synthesis Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Synthesis Service Market Size (2019-2030)
10.2 Middle East & Africa Peptide Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peptide Synthesis Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Peptide Synthesis Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Detail
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Synthesis Service Introduction
11.1.4 Bachem Revenue in Peptide Synthesis Service Business (2019-2024)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Detail
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide Synthesis Service Introduction
11.2.4 PolyPeptide Revenue in Peptide Synthesis Service Business (2019-2024)
11.2.5 PolyPeptide Recent Development
11.3 GL Biochem
11.3.1 GL Biochem Company Detail
11.3.2 GL Biochem Business Overview
11.3.3 GL Biochem Peptide Synthesis Service Introduction
11.3.4 GL Biochem Revenue in Peptide Synthesis Service Business (2019-2024)
11.3.5 GL Biochem Recent Development
11.4 Xinbang
11.4.1 Xinbang Company Detail
11.4.2 Xinbang Business Overview
11.4.3 Xinbang Peptide Synthesis Service Introduction
11.4.4 Xinbang Revenue in Peptide Synthesis Service Business (2019-2024)
11.4.5 Xinbang Recent Development
11.5 Hybio
11.5.1 Hybio Company Detail
11.5.2 Hybio Business Overview
11.5.3 Hybio Peptide Synthesis Service Introduction
11.5.4 Hybio Revenue in Peptide Synthesis Service Business (2019-2024)
11.5.5 Hybio Recent Development
11.6 USVPeptides
11.6.1 USVPeptides Company Detail
11.6.2 USVPeptides Business Overview
11.6.3 USVPeptides Peptide Synthesis Service Introduction
11.6.4 USVPeptides Revenue in Peptide Synthesis Service Business (2019-2024)
11.6.5 USVPeptides Recent Development
11.7 Thermofischer
11.7.1 Thermofischer Company Detail
11.7.2 Thermofischer Business Overview
11.7.3 Thermofischer Peptide Synthesis Service Introduction
11.7.4 Thermofischer Revenue in Peptide Synthesis Service Business (2019-2024)
11.7.5 Thermofischer Recent Development
11.8 ScinoPharm
11.8.1 ScinoPharm Company Detail
11.8.2 ScinoPharm Business Overview
11.8.3 ScinoPharm Peptide Synthesis Service Introduction
11.8.4 ScinoPharm Revenue in Peptide Synthesis Service Business (2019-2024)
11.8.5 ScinoPharm Recent Development
11.9 Genscript
11.9.1 Genscript Company Detail
11.9.2 Genscript Business Overview
11.9.3 Genscript Peptide Synthesis Service Introduction
11.9.4 Genscript Revenue in Peptide Synthesis Service Business (2019-2024)
11.9.5 Genscript Recent Development
11.10 AnaSpec
11.10.1 AnaSpec Company Detail
11.10.2 AnaSpec Business Overview
11.10.3 AnaSpec Peptide Synthesis Service Introduction
11.10.4 AnaSpec Revenue in Peptide Synthesis Service Business (2019-2024)
11.10.5 AnaSpec Recent Development
11.11 New England Peptide
11.11.1 New England Peptide Company Detail
11.11.2 New England Peptide Business Overview
11.11.3 New England Peptide Peptide Synthesis Service Introduction
11.11.4 New England Peptide Revenue in Peptide Synthesis Service Business (2019-2024)
11.11.5 New England Peptide Recent Development
11.12 CPC Scientific
11.12.1 CPC Scientific Company Detail
11.12.2 CPC Scientific Business Overview
11.12.3 CPC Scientific Peptide Synthesis Service Introduction
11.12.4 CPC Scientific Revenue in Peptide Synthesis Service Business (2019-2024)
11.12.5 CPC Scientific Recent Development
11.13 JPT
11.13.1 JPT Company Detail
11.13.2 JPT Business Overview
11.13.3 JPT Peptide Synthesis Service Introduction
11.13.4 JPT Revenue in Peptide Synthesis Service Business (2019-2024)
11.13.5 JPT Recent Development
11.14 21st Century Bio
11.14.1 21st Century Bio Company Detail
11.14.2 21st Century Bio Business Overview
11.14.3 21st Century Bio Peptide Synthesis Service Introduction
11.14.4 21st Century Bio Revenue in Peptide Synthesis Service Business (2019-2024)
11.14.5 21st Century Bio Recent Development
11.15 LifeTein
11.15.1 LifeTein Company Detail
11.15.2 LifeTein Business Overview
11.15.3 LifeTein Peptide Synthesis Service Introduction
11.15.4 LifeTein Revenue in Peptide Synthesis Service Business (2019-2024)
11.15.5 LifeTein Recent Development
11.16 Proimmune
11.16.1 Proimmune Company Detail
11.16.2 Proimmune Business Overview
11.16.3 Proimmune Peptide Synthesis Service Introduction
11.16.4 Proimmune Revenue in Peptide Synthesis Service Business (2019-2024)
11.16.5 Proimmune Recent Development
11.17 Biomatik
11.17.1 Biomatik Company Detail
11.17.2 Biomatik Business Overview
11.17.3 Biomatik Peptide Synthesis Service Introduction
11.17.4 Biomatik Revenue in Peptide Synthesis Service Business (2019-2024)
11.17.5 Biomatik Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details